ClinicalTrials.gg

TargetBeta

TYK2

tyrosine kinase 2 · also JTK1 · FERM domain containing

13 programs in company-led studies act on TYK2, from 12 companies: 7 in phase 3, 5 approved with new studies. Each with where its target was read from.

Programs

Furthest phase first. A target read by rule is marked rule (10 of them); the others are the company’s own words or a reading by Claude, each quoted on the program’s page.

ProgramCompanyFurthest phaseStudiesAlso acts onRead from
upadacitinibruleAbbViephase 46424 runningJAK1, JAK2, JAK3ChEMBL
ruxolitinibruleIncytephase 49518 runningJAK1, JAK2, JAK3ChEMBL
deucravacitinibruleBristol-Myers Squibbphase 46012 running–ChEMBL
tofacitinibrulePfizerphase 4943 runningJAK1, JAK2, JAK3ChEMBL
filgotinib maleateruleEisaiphase 421 runningJAK1, JAK2, JAK3ChEMBL
D-2570ruleInventisBiophase 31311 running–the studies' text
filgotinibruleLakefront Biotherapeutics NVphase 3464 runningJAK1, JAK2, JAK3ChEMBL
HS-10374Hansoh Pharmaceutical Groupphase 364 running–the company's pipeline
TQH3906Sino Biopharmaceuticalphase 364 running–the company's pipeline
FXS5626Fosun Pharmaphase 333 runningJAK1the company's pipeline
brepocitinibrulePfizerphase 3252 runningJAK1NCIt
delgocitinibruleLEO Pharmaphase 3212 runningJAK1, JAK2, JAK3ChEMBL
TYK2 InhibitorruleUsynova Pharmaceuticalsno phase11 running–NCIt

Also acted on by the same programs

Conditions their studies are in

Primary completions ahead

Each program’s next study to reach its primary completion, by the sponsor’s estimate.

What this can’t show

  • Only programs whose target has been read: most early programs are named only by a code and their companies do not say what they act on.
  • A target read by rule can be wrong; each program’s page quotes the words it was read from.
  • “Acts on” does not say how: an agonist and an antagonist of the same receptor are listed together (avexitide blocks the GLP-1 receptor that semaglutide activates).
  • Programs in company-led studies on ClinicalTrials.gov with a study in the last two years; academic studies and other registries are not counted here.